NODE 302: Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular - Adventist HealthCare

Clinical Trial Details

NODE 302

NODE 302: Multi-Centre, Open-Label, Safety Study of Etripamil Nasal Spray in Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia the NODE-302 trial (Extension of NODE-301)

Purpose/Objective

Request Additional Trial Information
Full Trial Details: ClinicalTrials.gov

Condition: Paroxysmal supraventricular tachycardia (PSVT)
Study Type: Interventional
Phase: Phase III
Study Start Date: 12/10/2018
Study Completion Date: 12/2021

This study is an extension of the NODE-301 efficacy study to evaluate the safety of etripamil NS 70 mg when self-administered by patients for spontaneous episodes of PSVT in an outpatient setting

NCT Number
NCT03635996
Principal Investigator(s)
Sean Beinart, MD
Sponsor(s)
Milestone Pharmaceuticals
Participant Eligibility
  • Age: 18 years and older
  • Gender: Male, Female

Location

  • Adventist HealthCare Shady Grove Medical Center
    9901 Medical Center Drive
    Rockville, MD 20850
    Main: 240-826-6000
    Alternate: 240-826-6405

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.